357 related articles for article (PubMed ID: 26836192)
1. Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation.
Smith R; Wibom M; Olsson T; Hägerström D; Jögi J; Rabinovici GD; Hansson O
J Alzheimers Dis; 2016; 51(2):339-43. PubMed ID: 26836192
[TBL] [Abstract][Full Text] [Related]
2. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
3. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
5. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
6. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
Nihashi T; Sakurai K; Kato T; Iwata K; Kimura Y; Ikenuma H; Yamaoka A; Takeda A; Arahata Y; Washimi Y; Suzuki K; Bundo M; Sakurai T; Okamura N; Yanai K; Ito K; Nakamura A;
J Alzheimers Dis; 2022; 85(1):223-234. PubMed ID: 34776443
[TBL] [Abstract][Full Text] [Related]
8. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.
Rabinovici GD; Furst AJ; Alkalay A; Racine CA; O'Neil JP; Janabi M; Baker SL; Agarwal N; Bonasera SJ; Mormino EC; Weiner MW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ
Brain; 2010 Feb; 133(Pt 2):512-28. PubMed ID: 20080878
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
[TBL] [Abstract][Full Text] [Related]
10. How the cognitive reserve interacts with β-amyloid deposition in mitigating FDG metabolism: An observational study.
Carapelle E; Serra L; Modoni S; Falcone M; Caltagirone C; Bozzali M; Specchio LM; Avolio C
Medicine (Baltimore); 2017 Apr; 96(16):e5876. PubMed ID: 28422821
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.
Hanseeuw BJ; Betensky RA; Schultz AP; Papp KV; Mormino EC; Sepulcre J; Bark JS; Cosio DM; LaPoint M; Chhatwal JP; Rentz DM; Sperling RA; Johnson KA
Ann Neurol; 2017 Apr; 81(4):583-596. PubMed ID: 28253546
[TBL] [Abstract][Full Text] [Related]
12. In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
Dronse J; Fliessbach K; Bischof GN; von Reutern B; Faber J; Hammes J; Kuhnert G; Neumaier B; Onur OA; Kukolja J; van Eimeren T; Jessen F; Fink GR; Klockgether T; Drzezga A
J Alzheimers Dis; 2017; 55(2):465-471. PubMed ID: 27802224
[TBL] [Abstract][Full Text] [Related]
13. Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.
Smith R; Wibom M; Pawlik D; Englund E; Hansson O
JAMA Neurol; 2019 Mar; 76(3):310-317. PubMed ID: 30508025
[TBL] [Abstract][Full Text] [Related]
14. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
[TBL] [Abstract][Full Text] [Related]
15. What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
Andriuta D; Moullart V; Schraen S; Devendeville A; Meyer ME; Godefroy O;
J Alzheimers Dis; 2016; 51(3):793-800. PubMed ID: 26923012
[TBL] [Abstract][Full Text] [Related]
16. Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.
Knight WD; Okello AA; Ryan NS; Turkheimer FE; Rodríguez Martinez de Llano S; Edison P; Douglas J; Fox NC; Brooks DJ; Rossor MN
Brain; 2011 Jan; 134(Pt 1):293-300. PubMed ID: 21084313
[TBL] [Abstract][Full Text] [Related]
17. Presenilin-1 mutation is associated with a hippocampus defect in alzheimer's disease: Meta-Analysis for neuroimaging research.
Gu X; Zhao M; Han X; Liu L
Clin Neurol Neurosurg; 2020 Apr; 191():105679. PubMed ID: 32004985
[TBL] [Abstract][Full Text] [Related]
18. Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease.
Guzmán-Vélez E; Diez I; Schoemaker D; Pardilla-Delgado E; Vila-Castelar C; Fox-Fuller JT; Baena A; Sperling RA; Johnson KA; Lopera F; Sepulcre J; Quiroz YT
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2113641119. PubMed ID: 35380901
[TBL] [Abstract][Full Text] [Related]
19. Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis.
Lyoo CH; Cho H; Choi JY; Hwang MS; Hong SK; Kim YJ; Ryu YH; Lee MS
J Alzheimers Dis; 2016; 51(3):671-5. PubMed ID: 26890779
[TBL] [Abstract][Full Text] [Related]
20. Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.
Tetzloff KA; Graff-Radford J; Martin PR; Tosakulwong N; Machulda MM; Duffy JR; Clark HM; Senjem ML; Schwarz CG; Spychalla AJ; Drubach DA; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
J Alzheimers Dis; 2018; 62(4):1713-1724. PubMed ID: 29614676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
